Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down0.15% Nasdaq Down0.12%

Biogen Idec Inc. (BIIB)

-NasdaqGS

209.28 Down 1.43(0.68%) 4:00PM EDT|After Hours : 208.70 Down 0.58 (0.28%) 5:04PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue 1,415,096   1,417,941   1,385,554   1,420,952  
Cost of Revenue133,749  133,828  139,358  139,111  
Gross Profit 1,281,347   1,284,113   1,246,196   1,281,841  
Operating Expenses
Research Development284,340  345,181  304,217  329,559  
Selling General and Administrative440,232  457,550  384,633  393,138  
Non Recurring -   -  803  1,139  
Others51,301  50,948  53,013  52,282  
Total Operating Expenses -   -  742,666  776,118  
Operating Income or Loss 510,525   445,507   535,249   505,723  
Income from Continuing Operations
Total Other Income/Expenses Net(9,406)783  27,171  2,950  
Earnings Before Interest And Taxes501,119  446,290  562,420  508,673  
Interest Expense -   -   -   -  
Income Before Tax501,119  446,290  562,420  508,673  
Income Tax Expense65,508  136,341  131,044  121,021  
Minority Interest -   -   -  (295)
Net Income From Continuing Ops431,800  307,200  430,118  386,846  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 426,749   292,127   398,399   386,846  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 426,749   292,127   398,399   386,846  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.